Thu, June 13, 2024

Sumant Kulkarni Downgraded (CARA) to Hold and Decreased Target to $1 on, Jun 13th, 2024

Sumant Kulkarni of Canaccord Genuity, Downgraded "Cara Therapeutics, Inc." (CARA) to Hold and Decreased Target from $10 to $1 on, Jun 13th, 2024.

Sumant, nor any peers, have made any analyst calls on CARA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30